[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.

Property Value
dbo:abstract
  • The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer. Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance to the field, and commitment to collaborations with like-minded organizations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community in an effort to make cancer immunotherapy one of the four standards of care and the word “cure” a reality for cancer patients living with this disease. The goals of SITC are directed towards the rapid dissemination of information in these areas to expedite the safe transfer of both basic and applied research to the clinical setting. (en)
dbo:headquarter
dbo:leaderFunction
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 18131320 (xsd:integer)
dbo:wikiPageLength
  • 11726 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1118873321 (xsd:integer)
dbo:wikiPageWikiLink
dbp:formation
  • 1984 (xsd:integer)
dbp:headquarters
dbp:keyPeople
  • Vice President: Leisha Emens, MD, PHD - UPMC Hillman Cancer Center Secretary/Treasurer: Jedd Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center Immediate Past President: Mario Sznol, MD - Yale School of Medicine (en)
dbp:language
  • English (en)
dbp:leaderName
  • Mary Dean, JD, CAE (en)
  • Patrick Hwu, MD - Moffitt Cancer Center (en)
dbp:leaderTitle
  • President (en)
  • Executive Director (en)
dbp:name
  • Society for Immunotherapy of Cancer (en)
dbp:type
  • Non-Profit Medical Society (en)
dbp:website
dbp:wikiPageUsesTemplate
dct:subject
schema:sameAs
rdf:type
rdfs:comment
  • The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer. (en)
rdfs:label
  • Society for Immunotherapy of Cancer (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Society for Immunotherapy of Cancer (SITC) (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License